These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24412608)

  • 21. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microparticles generated during chronic cerebral ischemia deliver proapoptotic signals to cultured endothelial cells.
    Schock SC; Edrissi H; Burger D; Cadonic R; Hakim A; Thompson C
    Biochem Biophys Res Commun; 2014 Jul; 450(1):912-7. PubMed ID: 24976400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver.
    Nakajima H; Mizuta N; Fujiwara I; Sakaguchi K; Ogata H; Magae J; Yagita H; Koji T
    Apoptosis; 2008 Aug; 13(8):1013-21. PubMed ID: 18561025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.
    Ku NO; Soetikno RM; Omary MB
    Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of TRAIL and its receptors in viral hepatitis.
    Mundt B; Kühnel F; Zender L; Paul Y; Tillmann H; Trautwein C; Manns MP; Kubicka S
    FASEB J; 2003 Jan; 17(1):94-6. PubMed ID: 12475902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
    Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
    Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targeting of CD95 and the TRAIL death receptors.
    Gerspach J; Pfizenmaier K; Wajant H
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):294-310. PubMed ID: 21762072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential].
    Busso V; Smirne C; Ferrero I; Segir R; Abrate S; Bellone G; Emanuelli G
    Minerva Med; 2001 Apr; 92(2):99-111. PubMed ID: 11323572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes.
    Ding WX; Ni HM; DiFrancesca D; Stolz DB; Yin XM
    Hepatology; 2004 Aug; 40(2):403-13. PubMed ID: 15368445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell death and cell death responses in liver disease: mechanisms and clinical relevance.
    Luedde T; Kaplowitz N; Schwabe RF
    Gastroenterology; 2014 Oct; 147(4):765-783.e4. PubMed ID: 25046161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Death receptor-mediated apoptosis and the liver.
    Yoon JH; Gores GJ
    J Hepatol; 2002 Sep; 37(3):400-10. PubMed ID: 12175638
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis.
    Wree A; Holtmann TM; Inzaugarat ME; Feldstein AE
    Semin Liver Dis; 2019 Jul; 39(3):275-282. PubMed ID: 31100758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell Death in Liver Diseases: A Review.
    Shojaie L; Iorga A; Dara L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration.
    Lauschke VM; Mkrtchian S; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 2017 Jan; 482(3):399-407. PubMed ID: 27789285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability.
    Mazzolini G; Sowa JP; Canbay A
    Clin Sci (Lond); 2016 Dec; 130(23):2121-2138. PubMed ID: 27798227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs: emerging biomarkers of liver disease.
    Arrese M; Eguchi A; Feldstein AE
    Semin Liver Dis; 2015 Feb; 35(1):43-54. PubMed ID: 25632934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis in diseases of the liver.
    Neuman MG
    Crit Rev Clin Lab Sci; 2001 Apr; 38(2):109-66. PubMed ID: 11347718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.